Cambridge Investment Research Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Buy |
241,056
+17,039
| +8% | +$1.37M | 0.04% | 433 |
|
|
2026
Q1 | $19.4M | Buy |
224,017
+12,245
| +6% | +$1.17M | 0.05% | 385 |
|
|
2025
Q4 | $20.3M | Buy |
211,772
+9,827
| +5% | +$955K | 0.05% | 362 |
|
|
2025
Q3 | $19.2M | Buy |
201,945
+22,140
| +12% | +$2.04M | 0.05% | 355 |
|
|
2025
Q2 | $15.7M | Buy |
179,805
+3,367
| +2% | +$286K | 0.05% | 397 |
|
|
2025
Q1 | $15.9M | Buy |
176,438
+24,777
| +16% | +$2.22M | 0.05% | 356 |
|
|
2024
Q4 | $12.1M | Sell |
151,661
-35,567
| -19% | -$3.08M | 0.04% | 424 |
|
|
2024
Q3 | $16.9M | Sell |
187,228
-509
| -0.3% | -$42.8K | 0.06% | 329 |
|
|
2024
Q2 | $14.8M | Sell |
187,737
-5,437
| -3% | -$446K | 0.05% | 349 |
|
|
2024
Q1 | $16.8M | Buy |
193,174
+792
| +0.4% | +$67.6K | 0.06% | 295 |
|
|
2023
Q4 | $15.8M | Buy |
192,382
+7,543
| +4% | +$575K | 0.07% | 282 |
|
|
2023
Q3 | $14.5M | Sell |
184,839
-1,543
| -0.8% | -$129K | 0.07% | 281 |
|
|
2023
Q2 | $16.4M | Buy |
186,382
+1,155
| +0.6% | +$99.4K | 0.07% | 262 |
|
|
2023
Q1 | $14.9M | Buy |
185,227
+31,512
| +21% | +$2.57M | 0.07% | 267 |
|
|
2022
Q4 | $11.9M | Sell |
153,715
-449
| -0.3% | -$36.4K | 0.06% | 313 |
|
|
2022
Q3 | $12.4M | Buy |
154,164
+5,282
| +4% | +$475K | 0.07% | 273 |
|
|
2022
Q2 | $13.4M | Buy |
148,882
+8,698
| +6% | +$881K | 0.07% | 260 |
|
|
2022
Q1 | $15.6M | Sell |
140,184
-1,351
| -1% | -$143K | 0.07% | 262 |
|
|
2021
Q4 | $14.6M | Buy |
141,535
+10,957
| +8% | +$1.27M | 0.07% | 279 |
|
|
2021
Q3 | $16.4M | Buy |
130,578
+1,235
| +1% | +$160K | 0.08% | 242 |
|
|
2021
Q2 | $16.1M | Buy |
129,343
+2,774
| +2% | +$348K | 0.08% | 248 |
|
|
2021
Q1 | $15M | Buy |
126,569
+8,243
| +7% | +$966K | 0.08% | 241 |
|
|
2020
Q4 | $13.9M | Sell |
118,326
-13,967
| -11% | -$1.54M | 0.08% | 233 |
|
|
2020
Q3 | $13.7M | Sell |
132,293
-42,924
| -24% | -$4.31M | 0.09% | 216 |
|
|
2020
Q2 | $16.1M | Buy |
175,217
+5,303
| +3% | +$509K | 0.12% | 184 |
|
|
2020
Q1 | $15.3M | Sell |
169,914
-5,589
| -3% | -$595K | 0.15% | 148 |
|
|
2019
Q4 | $19.9M | Buy |
175,503
+61,295
| +54% | +$6.73M | 0.15% | 138 |
|
|
2019
Q3 | $12.4M | Buy |
114,208
+15,642
| +16% | +$1.63M | 0.11% | 187 |
|
|
2019
Q2 | $9.6M | Buy |
98,566
+9,390
| +11% | +$857K | 0.09% | 232 |
|
|
2019
Q1 | $8.12M | Buy |
89,176
+4,735
| +6% | +$424K | 0.08% | 246 |
|
|
2018
Q4 | $7.68M | Buy |
84,441
+2,974
| +4% | +$278K | 0.08% | 226 |
|
|
2018
Q3 | $8.01M | Buy |
81,467
+3,893
| +5% | +$360K | 0.08% | 251 |
|
|
2018
Q2 | $6.64M | Buy |
77,574
+7,259
| +10% | +$606K | 0.07% | 261 |
|
|
2018
Q1 | $5.64M | Buy |
70,315
+6,605
| +10% | +$545K | 0.06% | 288 |
|
|
2017
Q4 | $5.14M | Buy |
63,710
+9,089
| +17% | +$728K | 0.06% | 303 |
|
|
2017
Q3 | $4.25M | Buy |
54,621
+3,173
| +6% | +$263K | 0.06% | 310 |
|
|
2017
Q2 | $4.57M | Sell |
51,448
-5,460
| -10% | -$460K | 0.07% | 277 |
|
|
2017
Q1 | $4.58M | Sell |
56,908
-1,007
| -2% | -$78.7K | 0.08% | 247 |
|
|
2016
Q4 | $4.13M | Sell |
57,915
-475
| -0.8% | -$37.3K | 0.08% | 241 |
|
|
2016
Q3 | $5.04M | Sell |
58,390
-4,887
| -8% | -$426K | 0.09% | 201 |
|
|
2016
Q2 | $5.49M | Buy |
63,277
+16,097
| +34% | +$1.3M | 0.12% | 163 |
|
|
2016
Q1 | $3.54M | Sell |
47,180
-412
| -0.9% | -$31K | 0.08% | 228 |
|
|
2015
Q4 | $3.66M | Sell |
47,592
-4,724
| -9% | -$356K | 0.09% | 227 |
|
|
2015
Q3 | $3.5M | Buy |
+52,316
| New | +$3.85M | 0.1% | 197 |
|
|
2015
Q1 | – | Sell |
-59,635
| Closed | -$4.31M | – | 1436 |
|
|
2014
Q4 | $4.31M | Buy |
59,635
+2,318
| +4% | +$161K | 0.13% | 152 |
|
|
2014
Q3 | $3.55M | Buy |
57,317
+2,394
| +4% | +$152K | 0.1% | 183 |
|
|
2014
Q2 | $3.5M | Buy |
54,923
+5,001
| +10% | +$304K | 0.12% | 157 |
|
|
2014
Q1 | $3.07M | Sell |
49,922
-32,266
| -39% | -$1.88M | 0.12% | 161 |
|
|
2013
Q4 | $4.72M | Buy |
82,188
+892
| +1% | +$50.6K | 0.19% | 112 |
|
|
2013
Q3 | $4.33M | Sell |
81,296
-10,718
| -12% | -$577K | 0.19% | 116 |
|
|
2013
Q2 | $4.74M | Buy |
+92,014
| New | +$4.55M | 0.24% | 92 |
|
Other funds holding MDT
Cambridge Investment Research Advisors's MDT Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Medtronic (MDT) stake by 7.6% in Q2 2026, buying an estimated $1.37M and bringing the position to 241,056 shares worth $18.9M. The position accounts for 0.04% of the portfolio, ranked #433.
Cambridge Investment Research Advisors first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $20.3M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Cambridge Investment Research Advisors held 241,056 shares of Medtronic worth $18.9M as of Q2 2026.
- Cambridge Investment Research Advisors bought 17,039 Medtronic shares in Q2 2026, an estimated $1.37M.
- Medtronic made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #433 holding.
- Cambridge Investment Research Advisors first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Cambridge Investment Research Advisors's Medtronic position peaked at $20.3M in Q4 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.